Back to Search
Start Over
Audit of a multidisciplinary approach to improve management of community-acquired pneumonia
- Source :
- Eur J Hosp Pharm
- Publication Year :
- 2017
- Publisher :
- BMJ, 2017.
-
Abstract
- Background Community-acquired pneumonia (CAP) is a frequent cause of morbidity, mortality and hospital admission worldwide. An adequate choice of empirical antibiotic treatment and appropriate severity assessment of the disease are key aspects in the management of CAP. Objective To audit the adherence to standards of care, such as empirical prescribing of antibiotics, and evaluate the current multidisciplinary approach to the management of CAP. Method Records of patients with CAP were identified and examined for CURB65 score documentation, discussion notes with microbiology and prescribed antibiotic treatments. Results Out of the 62 patients identified, 32 had a CURB65 score documented in their medical notes and 59 had documented chest X-ray findings. 85.5% of cases were compliant with antibiotic prescribing guidelines. Conclusion The multidisciplinary approach has considerably improved compliance with most of the standards, especially adherence to empirical antibiotic guidelines, and ultimately the standard of care for patients with CAP.
- Subjects :
- medicine.medical_specialty
community-acquired pneumonia
pharmacist
curb65
Short Report
Pharmacist
Disease
Audit
030226 pharmacology & pharmacy
Antibiotic prescribing
03 medical and health sciences
Severity assessment
0302 clinical medicine
Community-acquired pneumonia
Multidisciplinary approach
medicine
030212 general & internal medicine
hospital
General Pharmacology, Toxicology and Pharmaceutics
Intensive care medicine
business.industry
medicine.disease
United Kingdom
Pneumonia
board round
business
multidisciplinary
Subjects
Details
- ISSN :
- 20479964 and 20479956
- Volume :
- 26
- Database :
- OpenAIRE
- Journal :
- European Journal of Hospital Pharmacy
- Accession number :
- edsair.doi.dedup.....124960ccb76154e13711b1c61108ce0f
- Full Text :
- https://doi.org/10.1136/ejhpharm-2017-001368